Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease

BACKGROUND: Deep remission (DR) is a treatment target in IBD associated with reduced hospitalization and improved outcome. Randomized control trial (RCT) data demonstrates efficacy of anti-TNFα agents in achieving DR; however, real-world data (RWD) can provide information complementary to RCTs, spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Alipour, Omeed, Gualti, Alakh, Shao, Ling, Zhang, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335971/
https://www.ncbi.nlm.nih.gov/pubmed/34344314
http://dx.doi.org/10.1186/s12876-021-01883-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335971/
https://www.ncbi.nlm.nih.gov/pubmed/34344314
http://dx.doi.org/10.1186/s12876-021-01883-6

Ejemplares similares